# Researchers Discover Distinct Biological Subtypes of Autism Using Brain Imaging
A new study published in Nature Neuroscience identifies distinct autism subtypes based on brain connectivity patterns, offering the first direct biological evidence that autism's varied presentations reflect real differences in how brains are wired.
Researchers used cross-species functional neuroimaging, comparing brain scans across humans and animal models, to map dysconnectivity patterns in autistic brains. Rather than treating autism as one condition, the team parsed these patterns into biologically separate subtypes. This approach moves beyond the assumption that autism's visible differences reflect underlying variation. Now researchers have proof.
The distinction matters for families and clinicians. Autism presents differently in different people. Some autistic individuals struggle primarily with social communication. Others experience repetitive behaviors as their most prominent trait. Some have intellectual disability alongside autism. Others don't. Until now, these differences seemed like a spectrum on a single continuum.
This research suggests something different: autism may involve multiple distinct neural pathways. Understanding which pathway applies to a specific child could eventually inform more tailored interventions and support strategies.
The cross-species approach strengthens the findings. By studying brain connectivity patterns in both humans and animal models, researchers can isolate which dysconnectivity patterns are core to autism and which may be secondary effects. This biological grounding makes the subtypes more than just descriptive categories.
Parents whose autistic children receive diagnoses often notice that cookie-cutter approaches don't work for their particular child. One intervention helps some autistic kids while barely touching others. This research explains why. Different biological subtypes may respond to different strategies.
The work doesn't change diagnosis tomorrow, but it points toward precision medicine in autism. Future evaluations might identify which subtype a child has, allowing clinicians to recommend interventions backed by evidence for that specific subtype rather than guessing what
